- from: endocrinology
lipid disorders
- Measurements-lipid disorders
- dyslipidemias
- Drug Treatment-lipid disorders
- Treatment of LDL-C (Lancet 2014;384:607)
- Treatment of other lipid fractions (Lancet 2014;384:618 & 626)
- 2018 ACC AHA Cholesterol Guidelines (Circ 2019;139:e1082)
- statins actions, side effects, and administration
| Condition | LDL-C Target |
|---|---|
| ACS + DM | < 55 mg/dL |
| ACS | < 70 mg/dL |
| Stable CAD | < 70 mg/dL |
| PAD + CAD | < 70 mg/dL |
| PAD | < 100 mg/dL |
| ACS, Stable CAD, PAD (TG > 200 mg/dL) | Non-HDL-C < 100 mg/dL |